首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
AcetazolamideCutaneous adverse drug reactions: 10 case reports
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2013年
/ 1474卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-013-6535-7
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:5 / 5
相关论文
共 50 条
[21]
First reports of adverse drug reactions
不详
论文数:
0
引用数:
0
h-index:
0
不详
DRUGS & THERAPY PERSPECTIVES,
2023,
39
(02)
: 57
-
57
[22]
Reports of Serious Adverse Drug Reactions
Gruszycki, M. R.
论文数:
0
引用数:
0
h-index:
0
机构:
Facultad de Agroindustrias Carrera Farmacia Universidad Nacional del Nordeste Chaco,
Gruszycki, M. R.
Alba, D. A.
论文数:
0
引用数:
0
h-index:
0
机构:
Facultad de Agroindustrias Carrera Farmacia Universidad Nacional del Nordeste Chaco,
Alba, D. A.
Gruszycki, A. E.
论文数:
0
引用数:
0
h-index:
0
机构:
Facultad de Agroindustrias Carrera Farmacia Universidad Nacional del Nordeste Chaco,
Gruszycki, A. E.
Tauguinas, A. L.
论文数:
0
引用数:
0
h-index:
0
机构:
Facultad de Agroindustrias Carrera Farmacia Universidad Nacional del Nordeste Chaco,
Tauguinas, A. L.
Osicka, R. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Facultad de Agroindustrias Carrera Farmacia Universidad Nacional del Nordeste Chaco,
Osicka, R. M.
DRUG SAFETY,
2008,
31
(10)
: 899
-
899
[23]
First reports of adverse drug reactions
Drugs & Therapy Perspectives,
2017,
33
(6)
: 277
-
278
[24]
First reports of adverse drug reactions
Drugs & Therapy Perspectives,
2016,
32
(5)
: 195
-
196
[25]
First reports of adverse drug reactions
不详
论文数:
0
引用数:
0
h-index:
0
不详
DRUGS & THERAPY PERSPECTIVES,
2019,
35
(08)
: 374
-
375
[26]
First reports of adverse drug reactions
不详
论文数:
0
引用数:
0
h-index:
0
不详
DRUGS & THERAPY PERSPECTIVES,
2018,
34
(11)
: 517
-
517
[27]
First reports of adverse drug reactions
不详
论文数:
0
引用数:
0
h-index:
0
不详
DRUGS & THERAPY PERSPECTIVES,
2018,
34
(03)
: 128
-
128
[28]
First reports of adverse drug reactions
不详
论文数:
0
引用数:
0
h-index:
0
不详
DRUGS & THERAPY PERSPECTIVES,
2024,
40
(05)
: 189
-
189
[29]
First reports of adverse drug reactions
Drugs & Therapy Perspectives,
2019,
35
: 485
-
485
[30]
First reports of adverse drug reactions
Drugs & Therapy Perspectives,
2016,
32
(7)
: 292
-
293
←
1
2
3
4
5
→